Lo CY - Search Results

1

The potential clinical relevance of serum vascular endothelial growth factor (VEGF) and VEGF-C in recurrent papillary thyroid carcinoma.

Yu XM, Lo CY, Lam AK, Lang BH, Leung P, Luk JM. Yu XM, et al. Among authors: lo cy. Surgery. 2008 Dec;144(6):934-40; discussion 940-1. doi: 10.1016/j.surg.2008.07.027. Surgery. 2008. PMID: 19041000

2

Impact of routine unilateral central neck dissection on preablative and postablative stimulated thyroglobulin levels after total thyroidectomy in papillary thyroid carcinoma.

Lang BH, Wong KP, Wan KY, Lo CY. Lang BH, et al. Among authors: lo cy. Ann Surg Oncol. 2012 Jan;19(1):60-7. doi: 10.1245/s10434-011-1833-x. Epub 2011 Jun 17. Ann Surg Oncol. 2012. PMID: 21681379 Free PMC article.

3

Applicability of tissue aspirate for quick parathyroid hormone assay to confirm parathyroid tissue identity during parathyroidectomy for primary hyperparathyroidism.

Lo CY, Chan WF, Leung P, Luk JM. Lo CY, et al. Arch Surg. 2005 Feb;140(2):146-9; discussion 150. doi: 10.1001/archsurg.140.2.146. Arch Surg. 2005. PMID: 15723995

4

High prevalence of cyclooxygenase 2 expression in papillary thyroid carcinoma.

Lo CY, Lam KY, Leung PP, Luk JM. Lo CY, et al. Eur J Endocrinol. 2005 Apr;152(4):545-50. doi: 10.1530/eje.1.01883. Eur J Endocrinol. 2005. PMID: 15817909

5

Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.

Yu XM, Lo CY, Chan WF, Lam KY, Leung P, Luk JM. Yu XM, et al. Among authors: lo cy. Clin Cancer Res. 2005 Nov 15;11(22):8063-9. doi: 10.1158/1078-0432.CCR-05-0646. Clin Cancer Res. 2005. PMID: 16299237

6

Classical and follicular variant of papillary thyroid carcinoma: a comparative study on clinicopathologic features and long-term outcome.

Lang BH, Lo CY, Chan WF, Lam AK, Wan KY. Lang BH, et al. Among authors: lo cy. World J Surg. 2006 May;30(5):752-8. doi: 10.1007/s00268-005-0356-7. World J Surg. 2006. PMID: 16680590

7

Papillary microcarcinoma: is there any difference between clinically overt and occult tumors?

Lo CY, Chan WF, Lang BH, Lam KY, Wan KY. Lo CY, et al. World J Surg. 2006 May;30(5):759-66. doi: 10.1007/s00268-005-0363-8. World J Surg. 2006. PMID: 16680591

8

Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging.

Lang BH, Lo CY, Chan WF, Lam KY, Wan KY. Lang BH, et al. Among authors: lo cy. Ann Surg Oncol. 2007 Feb;14(2):730-8. doi: 10.1245/s10434-006-9207-5. Epub 2006 Nov 11. Ann Surg Oncol. 2007. PMID: 17103065

9

The role of intraoperative neuromonitoring of recurrent laryngeal nerve during thyroidectomy: a comparative study on 1000 nerves at risk.

Chan WF, Lang BH, Lo CY. Chan WF, et al. Among authors: lo cy. Surgery. 2006 Dec;140(6):866-72; discussion 872-3. doi: 10.1016/j.surg.2006.07.017. Epub 2006 Sep 18. Surgery. 2006. PMID: 17188132

10

Staging systems for papillary thyroid carcinoma: a review and comparison.

Lang BH, Lo CY, Chan WF, Lam KY, Wan KY. Lang BH, et al. Among authors: lo cy. Ann Surg. 2007 Mar;245(3):366-78. doi: 10.1097/01.sla.0000250445.92336.2a. Ann Surg. 2007. PMID: 17435543 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

588 results

Search Page

Filters